Your epilepsy treatment team
Northeast Regional Epilepsy Group
All year long, the Northeast Regional Epilepsy Group promotes epilepsy education for patients, their caregivers, medical treatment staff, and the general public. Team Northeast Regional Epilepsy Group participates in several epilepsy walks and many different fundraising activities that directly benefit the national or local epilepsy foundations and advocacy societies. Check out our upcoming schedule and you may find an activity that interests you.

 

Ongoing Research Projects

The Northeast Regional Epilepsy Group is currently conducting the following research projects in epilepsy.  Contact us if you wish to participate and we will examine your case and let you know if you could be a candidate.

1. A Phase 2, Randomized, Double-blind, Placebo-controlled Study of VX-765 in Subjects with Treatment-resistant Partial Seizures

2. Efficacy and safety of eslicarbazepine acetate (BIA 2-093) as adjunctive therapy for refractory partial seizures in a double-blind, randomized, placebo-controlled, parallel-group, multicentre clinical trial.

3. Double-Blind, Randomized Efficacy and Safety study of Pregabalin (Lyrica) as monotherapy in patients with partial Epilepsy $100 compensation per subject and Pfizer will also provide 6 months of subject\'s regular AED in case they do not do well on Lyrica monotherapy.

4. Epilepsy alert device – Epilert Performance.  Principal Investigator: Georges Ghacibeh, M.D.

5. N01276/1306 - Double-Blind, Randomized, Parallel Group, Historical-Control Conversion to Monotherapy study to evaluate the efficacy and safety of Brivaracetam in subjects (> 16 to75 y/o) with partial seizures. Principal Investigator: Jeffrey Politsky, M.D.

6. A Phase 3 Randomized, Double-Blind, Placebo-Controlled Cross-Over Study of the Safety and Efficacy of Intranasal Midazolam in the Outpatient Treatment of Subjects with Seizure Clusters. Principal Investigator: Jeffrey Politsky, M.D.
 
7. An Open label, Randomized Study Prospectively Examining the Effect on Anxiety in Partial Epilepsy Patients Treated with Pregabalin. Principal Invesitgator: Evan Fertig, M.D.
 
8. Cognitive and behavioral effects of Lacosamide as adjunctive therapy in patients with partial epilepsy. Principal Investigator: Marcelo Lancman, M.D.

View more.

 



 

Previews News

National Walk for Epilepsy 2012 - Washington, DC
Purple Day
65th Annual Meeting of the American Epilepsy Society
Epilepsy: Taking Control - PATIENT EDUCATION CONFERENCE - November 19
Autism, Epilepsy and Seizures - November 16
EPILEPSY: A nursing perspective - FREE CEU program for nurses
Epilepsy: a Nursing Perspective - November 2011
Epilepsy: Taking Control - PATIENT EDUCATION CONFERENCE - November 5
Epilepsy: Taking Control - PATIENT EDUCATION CONFERENCE - November 2
Epilepsy Updates for Patients - October 27
Epilepsy Research Program
Epilepsy: Taking Control - PATIENT EDUCATION CONFERENCE - September 10
New Jersey Epilepsy Task Force
Educational conference for Patients and Loved Ones - July 23
Sara's Walk
Epilepsy Research Program
Stroll for Epilepsy
Walk for a Brighter Tomorrow - Seaside Heights NJ.
Epilepsy: Taking Control - PATIENT EDUCATION CONFERENCE
The Northeast Regional Epilepsy Group introduces new locations for it's memory treatment program for patients with epilepsy